The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

Release time:

2021-05-19

The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

On May 19, the group company successfully won the bidding for the mRNA nucleic acid coronavirus project of Siwei (Shanghai) Biotechnology Co., Ltd in Jinqiao, Shanghai as the EPC general contractor. This is the third new coronavirus vaccine project that Jiangsu Qi 'an has won after the Conxino Coronavirus vaccine project and the Beijing Kexing Zhongwei Coronavirus vaccine project, which were developed by Chen Wei, an academician of the Chinese Academy of Engineering. Sinomicrobiology is an innovative mRNA drug research and development company. With a tight construction period and high professional quality requirements, Sinomicrobiology Group has successfully won the bidding for the mRNA nucleic acid new crown vaccine project through a joint venture with China Pharmaceutical Corporation. "Sinopharmaceutical Engineering" is the top domestic design institute, known as "quality from design"; The Jinhui Branch of the Group, which is responsible for the construction, has been committed to the domestic high-end biomedical engineering for a long time with excellent professional technology, and is good at providing value-added services and creating value for the owners through professional construction technology. Not long ago, Jinhui Branch completed four production lines of Sinovac New Coronavirus Vaccine ahead of schedule and won high praise from all sides. Xu Bin, the person in charge of Jinhui, said that it would fully carry forward the professional and technical advantages of Jiangsu Qi 'an and its experience in the construction of Sinovac vaccine project, work together with the "Chinese Medicine Project" for 95 days to ensure the completion of the construction task with high quality, and help the "Sibiome" contribute to the realization of human victory over COVID-19. (Jinhui Branch)

The group held a legal work exchange meeting

Nantong installation and construction enterprise high quality development seminar held in the group company

Recommended news

2026-06-25

The Kuaike Haofudun project, undertaken by the Group, has officially entered production, and General Manager Zhang Jian was invited to attend the opening ceremony.

On the morning of June 25, the grand opening ceremony of Quake Haofudun Materials Technology (Suzhou) Co., Ltd. was held in the Zhangjiagang Free Trade Zone. Zhang Jian, General Manager of the Group, along with Deputy General Manager Shi Saicai and other invited guests, attended the event and jointly witnessed this significant milestone marking the project’s entry into production.

2026-06-24

The Group achieved excellent results in the preliminary round of the province-wide construction safety production knowledge competition.

Recently, the preliminary-round results of the province-wide construction‑site safety production knowledge competition were officially announced. The Group achieved an outstanding team performance, with six participants ranking in the top ten, placing first among all construction enterprises in the province.

2026-06-22

The Group’s Roche Pharmaceutical project employs air‑suspended air cushions to achieve non‑destructive construction.

In mid-June, the Roche Pharmaceuticals project, constructed by the Group’s Maosheng International Engineering Branch, successfully completed the indoor relocation of three 13-ton heavy-duty pieces of equipment within a high‑standard epoxy flooring area, utilizing an air‑suspension cushion‑lifting technique.

2026-06-10

Carrying forward the glory of military service, we uphold our spirit of dedication to peace and security.

On June 2, the “Carrying Forward the Glory of Military Service, Ensuring the Well-being of Veteran Soldiers” Care Foundation was officially established at the Qidong Municipal Bureau of Veterans Affairs and the Municipal Charity Federation, under the leadership of Gong Shancong, Deputy General Manager of the Group. The foundation aims to “show care for veterans, alleviate their difficulties, safeguard their health and well-being, and spread warmth throughout society.”

2026-06-05

The Group’s Roche Pharmaceutical Project has been awarded the One-Million-Safety-Hours Award.

On June 5, the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I) held a ceremony to celebrate reaching one million safe man-hours, and the Group was presented with a commemorative trophy.

2026-05-26

The Group convened a special meeting of the dedicated task force for major project services.

On the afternoon of May 25, the Group convened a special working meeting on major project services in the 16th-floor conference room, with senior management and all members of the Major Project Management Department in attendance. The meeting was chaired by Zhang Jian, General Manager of the Group.